Diaceutics PLC DXRX.L Stock
Diaceutics PLC Price Chart
Diaceutics PLC DXRX.L Financial and Trading Overview
Diaceutics PLC stock price | 133 GBP |
Previous Close | 86 GBP |
Open | 85.9 GBP |
Bid | 85 GBP x 0 |
Ask | 0 GBP x 0 |
Day's Range | 85.9 - 85.9 GBP |
52 Week Range | 74 - 118 GBP |
Volume | 11.63K GBP |
Avg. Volume | 45.3K GBP |
Market Cap | 74.67M GBP |
Beta (5Y Monthly) | 0.324964 |
PE Ratio (TTM) | 85.9 |
EPS (TTM) | -0.02 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 170.67 GBP |
DXRX.L Valuation Measures
Enterprise Value | 53.96M GBP |
Trailing P/E | 85.9 |
Forward P/E | -0.2726984 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.8285046 |
Price/Book (mrq) | 170.09901 |
Enterprise Value/Revenue | 2.766 |
Enterprise Value/EBITDA | 25.99 |
Trading Information
Diaceutics PLC Stock Price History
Beta (5Y Monthly) | 0.324964 |
52-Week Change | -13.99% |
S&P500 52-Week Change | 20.43% |
52 Week High | 118 GBP |
52 Week Low | 74 GBP |
50-Day Moving Average | 93.8 GBP |
200-Day Moving Average | 90.05 GBP |
DXRX.L Share Statistics
Avg. Volume (3 month) | 45.3K GBP |
Avg. Daily Volume (10-Days) | 120.7K GBP |
Shares Outstanding | 84.47M |
Float | 46.53M |
Short Ratio | N/A |
% Held by Insiders | 46.78% |
% Held by Institutions | 47.41% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.71% |
Operating Margin (ttm) | 2.94% |
Gross Margin | 85.83% |
EBITDA Margin | 10.64% |
Management Effectiveness
Return on Assets (ttm) | 0.77% |
Return on Equity (ttm) | 1.74% |
Income Statement
Revenue (ttm) | 19.5M GBP |
Revenue Per Share (ttm) | 0.23 GBP |
Quarterly Revenue Growth (yoy) | 50.10% |
Gross Profit (ttm) | 16.74M GBP |
EBITDA | 2.08M GBP |
Net Income Avi to Common (ttm) | 724K GBP |
Diluted EPS (ttm) | 0.01 |
Quarterly Earnings Growth (yoy) | 66.40% |
Balance Sheet
Total Cash (mrq) | 19.84M GBP |
Total Cash Per Share (mrq) | 0.24 GBP |
Total Debt (mrq) | 1.33M GBP |
Total Debt/Equity (mrq) | 3.13 GBP |
Current Ratio (mrq) | 8.235 |
Book Value Per Share (mrq) | 0.505 |
Cash Flow Statement
Operating Cash Flow (ttm) | 5.1M GBP |
Levered Free Cash Flow (ttm) | -354625 GBP |
Profile of Diaceutics PLC
Country | United Kingdom |
State | N/A |
City | Belfast |
Address | Building Two |
ZIP | BT9 6GW |
Phone | N/A |
Website | https://www.diaceutics.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 151 |
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Q&A For Diaceutics PLC Stock
What is a current DXRX.L stock price?
Diaceutics PLC DXRX.L stock price today per share is 133 GBP.
How to purchase Diaceutics PLC stock?
You can buy DXRX.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Diaceutics PLC?
The stock symbol or ticker of Diaceutics PLC is DXRX.L.
Which industry does the Diaceutics PLC company belong to?
The Diaceutics PLC industry is Diagnostics & Research.
How many shares does Diaceutics PLC have in circulation?
The max supply of Diaceutics PLC shares is 844.61K.
What is Diaceutics PLC Price to Earnings Ratio (PE Ratio)?
Diaceutics PLC PE Ratio is now.
What was Diaceutics PLC earnings per share over the trailing 12 months (TTM)?
Diaceutics PLC EPS is -0.02 GBP over the trailing 12 months.
Which sector does the Diaceutics PLC company belong to?
The Diaceutics PLC sector is Healthcare.